Skip to main content

Table 1 Relationship between patient characteristics and HOXA-AS3 expression levels in tissues

From: LncRNA HOXA-AS3 promotes gastric cancer progression by regulating miR-29a-3p/LTβR and activating NF-κB signaling

Clinicopathologic features

n

HOXA-AS3 expression

χ2

P value

Low

High

Gender

   

0.467

0.464

 Male

51

27

24

  

 Female

31

14

17

  

Age (years)

   

0.668

0.414

  ≤ 50

17

7

10

  

  > 50

65

34

31

  

Tumor diameter (cm)

   

9.848

0.002**

  ≤ 4

48

31

17

  

  > 4

34

10

24

  

Tumor location

   

0.201

0.654

 Up + Middle

34

16

18

  

 Down

48

25

23

  

Tumor differentiation

   

2.390

0.122

 High + Middle

41

24

17

  

 Low

41

17

24

  

CEA level (ng/ml)

   

3.514

0.061

   ≤ 5

70

38

32

  

   > 5

12

3

9

  

CA 19-9 level (U/ml)

   

1.242

0.265

  ≤ 37

66

35

31

  

   > 37

16

6

10

  

HP infection

   

3.989

0.046*

  −

37

23

14

  

   + 

45

18

27

  

T stage

   

20.500

 < 0.0001****

 T1-2

32

26

6

  

 T3-4

50

15

35

  

N stage

   

25.866

 < 0.0001****

 N0

39

31

8

  

 N1-3

43

10

33

  
  1. *< 0.05; **< 0.01; ****< 0.0001